Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing a new version of the page. This is a metadata-level update rather than a change to study-specific information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s displayed revision/version has been updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded glossary term: Mucopolysaccharidosis, MPS-II. Removed glossary term: Mucopolysaccharidosis type 2.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.5.0. The previous Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor maintenance update and does not affect study content or eligibility details.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.